Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort

Chiara Scoccianti, Aurélien Vesin, Ghislaine Martel, Magali Olivier, Elisabeth Brambilla, Jean François Timsit, Luca Tavecchio, Christian Brambilla, John K. Field, Pierre Hainaut, J. K. Field, C. Brambilla, Y. Martinet, E. Thunnissen, P. Snijders, G. Sozzi, A. Risch, S. Elborn, L. M. Montuenga, K. O'ByrneD. J. Harrison, J. Niklinski

Research output: Contribution to journalArticle

Abstract

Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR genes. The series included 11 never-smokers, 86 former smokers, 152 current smokers and one patient without informed smoking status. There were 110 squamous cell carcinomas (SCCs), 133 adenocarcinomas (ADCs) and seven large cell carcinomas or mixed histologies. Expression of p53 was analysed by immunohistochemistry. DNA was extracted from frozen tumour tissues. TP53 mutations were detected in 48.8% of cases and were more frequent among SCCs than ADCs (p

Original languageEnglish
Pages (from-to)177-184
Number of pages8
JournalEuropean Respiratory Journal
Volume40
Issue number1
DOIs
Publication statusPublished - Jul 1 2012

Fingerprint

Non-Small Cell Lung Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
erbB-1 Genes
Large Cell Carcinoma
Mutation
p53 Genes
Lung Neoplasms
Histology
Smoking
Immunohistochemistry
DNA
Neoplasms

Keywords

  • EGFR
  • KRAS
  • Mutations
  • Nonsmall cell lung cancer
  • Prognosis
  • TP53

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Scoccianti, C., Vesin, A., Martel, G., Olivier, M., Brambilla, E., Timsit, J. F., ... Niklinski, J. (2012). Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort. European Respiratory Journal, 40(1), 177-184. https://doi.org/10.1183/09031936.00097311

Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer : The EUELC cohort. / Scoccianti, Chiara; Vesin, Aurélien; Martel, Ghislaine; Olivier, Magali; Brambilla, Elisabeth; Timsit, Jean François; Tavecchio, Luca; Brambilla, Christian; Field, John K.; Hainaut, Pierre; Field, J. K.; Brambilla, C.; Martinet, Y.; Thunnissen, E.; Snijders, P.; Sozzi, G.; Risch, A.; Elborn, S.; Montuenga, L. M.; O'Byrne, K.; Harrison, D. J.; Niklinski, J.

In: European Respiratory Journal, Vol. 40, No. 1, 01.07.2012, p. 177-184.

Research output: Contribution to journalArticle

Scoccianti, C, Vesin, A, Martel, G, Olivier, M, Brambilla, E, Timsit, JF, Tavecchio, L, Brambilla, C, Field, JK, Hainaut, P, Field, JK, Brambilla, C, Martinet, Y, Thunnissen, E, Snijders, P, Sozzi, G, Risch, A, Elborn, S, Montuenga, LM, O'Byrne, K, Harrison, DJ & Niklinski, J 2012, 'Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort', European Respiratory Journal, vol. 40, no. 1, pp. 177-184. https://doi.org/10.1183/09031936.00097311
Scoccianti, Chiara ; Vesin, Aurélien ; Martel, Ghislaine ; Olivier, Magali ; Brambilla, Elisabeth ; Timsit, Jean François ; Tavecchio, Luca ; Brambilla, Christian ; Field, John K. ; Hainaut, Pierre ; Field, J. K. ; Brambilla, C. ; Martinet, Y. ; Thunnissen, E. ; Snijders, P. ; Sozzi, G. ; Risch, A. ; Elborn, S. ; Montuenga, L. M. ; O'Byrne, K. ; Harrison, D. J. ; Niklinski, J. / Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer : The EUELC cohort. In: European Respiratory Journal. 2012 ; Vol. 40, No. 1. pp. 177-184.
@article{0e21a6982af74ba6a32918f5f0a8fae0,
title = "Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort",
abstract = "Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR genes. The series included 11 never-smokers, 86 former smokers, 152 current smokers and one patient without informed smoking status. There were 110 squamous cell carcinomas (SCCs), 133 adenocarcinomas (ADCs) and seven large cell carcinomas or mixed histologies. Expression of p53 was analysed by immunohistochemistry. DNA was extracted from frozen tumour tissues. TP53 mutations were detected in 48.8{\%} of cases and were more frequent among SCCs than ADCs (p",
keywords = "EGFR, KRAS, Mutations, Nonsmall cell lung cancer, Prognosis, TP53",
author = "Chiara Scoccianti and Aur{\'e}lien Vesin and Ghislaine Martel and Magali Olivier and Elisabeth Brambilla and Timsit, {Jean Fran{\cc}ois} and Luca Tavecchio and Christian Brambilla and Field, {John K.} and Pierre Hainaut and Field, {J. K.} and C. Brambilla and Y. Martinet and E. Thunnissen and P. Snijders and G. Sozzi and A. Risch and S. Elborn and Montuenga, {L. M.} and K. O'Byrne and Harrison, {D. J.} and J. Niklinski",
year = "2012",
month = "7",
day = "1",
doi = "10.1183/09031936.00097311",
language = "English",
volume = "40",
pages = "177--184",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",

}

TY - JOUR

T1 - Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer

T2 - The EUELC cohort

AU - Scoccianti, Chiara

AU - Vesin, Aurélien

AU - Martel, Ghislaine

AU - Olivier, Magali

AU - Brambilla, Elisabeth

AU - Timsit, Jean François

AU - Tavecchio, Luca

AU - Brambilla, Christian

AU - Field, John K.

AU - Hainaut, Pierre

AU - Field, J. K.

AU - Brambilla, C.

AU - Martinet, Y.

AU - Thunnissen, E.

AU - Snijders, P.

AU - Sozzi, G.

AU - Risch, A.

AU - Elborn, S.

AU - Montuenga, L. M.

AU - O'Byrne, K.

AU - Harrison, D. J.

AU - Niklinski, J.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR genes. The series included 11 never-smokers, 86 former smokers, 152 current smokers and one patient without informed smoking status. There were 110 squamous cell carcinomas (SCCs), 133 adenocarcinomas (ADCs) and seven large cell carcinomas or mixed histologies. Expression of p53 was analysed by immunohistochemistry. DNA was extracted from frozen tumour tissues. TP53 mutations were detected in 48.8% of cases and were more frequent among SCCs than ADCs (p

AB - Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR genes. The series included 11 never-smokers, 86 former smokers, 152 current smokers and one patient without informed smoking status. There were 110 squamous cell carcinomas (SCCs), 133 adenocarcinomas (ADCs) and seven large cell carcinomas or mixed histologies. Expression of p53 was analysed by immunohistochemistry. DNA was extracted from frozen tumour tissues. TP53 mutations were detected in 48.8% of cases and were more frequent among SCCs than ADCs (p

KW - EGFR

KW - KRAS

KW - Mutations

KW - Nonsmall cell lung cancer

KW - Prognosis

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=84863486249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863486249&partnerID=8YFLogxK

U2 - 10.1183/09031936.00097311

DO - 10.1183/09031936.00097311

M3 - Article

C2 - 22267755

AN - SCOPUS:84863486249

VL - 40

SP - 177

EP - 184

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 1

ER -